SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-111123
Filing Date
2021-08-30
Accepted
2021-08-30 17:21:23
Documents
1
Group Members
DOUGLAS D. FRENCHJOE H. CUNNINGHAMKEVIN M. LALANDESANTE HEALTH VENTURES II, LPSHV MANAGEMENT SERVICES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a21-26428_1sc13d.htm SC 13D 274730
  Complete submission text file 0001104659-21-111123.txt   276504
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Subject) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86491 | Film No.: 211224557
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 WEST 5TH STREET, SUITE 1500 AUSTIN TX 78701
Business Address 201 WEST 5TH STREET, SUITE 1500 AUSTIN TX 78701 512-721-1200
SHV Management Services II, LP (Filed by) CIK: 0001880795 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D